Orthofix Reports Fourth Quarter and Full-Year 2024 Results and Provides 2025 Financial Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Nasdaq, S&P end lower as tech stocks fall
- Micron posts record profit as AI memory demand fuels explosive growth
- Brent settles at lowest since before start of Iran war as more tankers exit Hormuz
- All eyes on Micron earnings tonight as sell-off raises stakes for AI memory trade
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Rescue work underway after quakes rock Venezuela, 'high casualties' likely
- Needham Starts NeoVolta (NEOV) at Buy
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
BTIG Reiterates Neutral Rating on Orthofix International (OFIX)
February 25, 2025 1:01 PM ESTBTIG analyst Ryan Zimmerman reiterated a Neutral rating on Orthofix International (NASDAQ: OFIX).
The analyst comments "We maintain our Neutral following 4Q24 results. OFIX reported rev. of $215.7M (7.6% Y/Y, 7.8% xFx) above Cons. at $212.7M while adj. EBITDA of $23.9M beat Street ests. of $22.6M. Growth was driven by Global Orthopedics (18.1% Y/Y xFx) and BGT (8.6% Y/Y).... More
